Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF

Official title: A Pilot Study Evaluating Renal Denervation in Heart Failure Patients: A Two-Phase Prospective Study - Phase 1

Run by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · NCT07893821 · Data updated 2026-11-12

This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.

More Hypertension trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment10 (estimated)
SponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Academic / other
Locations1 site (London, Ontario)
StatusRecruiting
StartedAugust 1, 2026
Main results expectedAugust 2029
Study endsAugust 2029
Registry record updatedOctober 26, 2026
Trial IDNCT07893821 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older with atrial fibrillation scheduled for EP study or catheter ablation, and with eGFR ≥45 mL/min/1.73m².

Probably not a fit

Patients with significant renal artery disease, a single kidney, pregnancy, or other conditions that disallow safe catheter-based procedures may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot, two-phase study explores the safety and feasibility of catheter-based renal artery electrical stimulation as a precursor to renal denervation. Phase 1 focuses on accessing the renal arteries and observing immediate blood pressure responses to brief stimulation in patients scheduled for electrophysiology studies or ablation. The study targets adults with atrial fibrillation, hypertension, and HFpEF, and excludes those with significant renal dysfunction or high-risk conditions. If safety and feasibility are demonstrated, subsequent phases would further evaluate the approach as a potential option to manage blood pressure in this patient group.

Why it matters

Potential benefit: If successful, this approach could offer a new way to lower blood pressure and possibly reduce heart strain in patients with AF and HFpEF.

How similar studies have gone: Renal denervation and renal nerve modulation have shown blood pressure reductions in other groups, but benefits in AF with HFpEF are not yet established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥18 years
2. Scheduled for EP study +/- catheter ablation
3. Adequate renal function (eGFR ≥45 mL/min/1.73m²)

Exclusion Criteria:

1. Hemodynamic instability
2. Renal artery stenosis \>50%
3. Single functioning kidney
4. Previous renal artery intervention
5. Pregnancy or nursing
6. Life expectancy \<12 months
7. Unwilling or unable to provide informed consent
8. Participation in a clinical trial that may impact the outcomes of the current study

Where it's running

  • London Heart Rhythm Program
    London, Ontario, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.